On February 8th, 2023, CVS Health (NYSE:CVS) declared its quarterly earnings data, amplifying positive news for the pharmacy behemoth’s financial status. The pharmacy operator reported $1.99 earnings per share (EPS) for the quarter, which triumphed the consensus estimate of $1.92 by $0.07. Additionally, CVS Health had a return on equity of 15.75% and a net margin of 1.29%. Regardless, given the encouraging upwards trajectory in healthcare spending within a continually aging population, it is evident that pharmaceutical companies such as CVS Health may have growth opportunities ahead of them if appropriately capitalized upon. U.S. Healthcare Spending: Who Pays?

Source: Forbes April 25, 2023 15:30 UTC